Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT01825902
Eligibility Criteria:
Inclusion Criteria:
* Histological confirmation of newly diagnosed localized or newly diagnosed with metastatic Ewing sarcoma (ES) or primitive neuroectodermal tumor (PNET) of bone or soft tissue
* Planning to receive definitive RT or surgery with or without adjuvant RT
* Willing to sign release of information for any follow-up records
* Provide informed written consent if \>= 18 years; if \< 18 years, provide informed written assent and parent or legal guardian provide informed written consent
* Patients must have measurable disease
* Willingness to participate in mandatory imaging studies
* Willingness to provide mandatory pathology samples for correlative research
Exclusion Criteria:
* Unable to undergo MRI scans with contrast (e.g. cardiac pacemaker, defibrillator, kidney failure)
* Unable to undergo 18F-FLT PET scan
* Any of the following:
* Pregnant women
* Nursing women
* Men or women of childbearing potential who are unwilling to employ adequate contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Study:
NCT01825902
Study Brief:
Protocol Section:
NCT01825902